Brian H Dovey's Net Worth

$2.21 Million

Estimate Recalculated Nov 4, 2024 02:33AM EST

Who is Brian H Dovey

Brian H Dovey has an estimated net worth of $2.21 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, Volcano Corp, Bionano Genomics, Inc., Orexigen Therapeutics, Inc., ZOGENIX, INC., Northstar Neuroscience, Inc., CoLucid Pharmaceuticals, Inc., INTRALASE CORP, IOMAI CORP, TANDEM DIABETES CARE INC, MARINUS PHARMACEUTICALS INC, GLAUKOS Corp, VERACYTE, INC., Atara Biotherapeutics, Inc., Aldeyra Therapeutics, Inc., Vanda Pharmaceuticals Inc., Syndax Pharmaceuticals Inc, Esperion Therapeutics, Inc., Clovis Oncology, Inc., NUVASIVE INC, Alliqua BioMedical, Inc., OBALON THERAPEUTICS INC, Evoke Pharma Inc, aTYR PHARMA INC, ALIMERA SCIENCES INC, OTONOMY, INC., Neothetics, Inc., NOVACEA INC, Durata Therapeutics, Inc., REVA Medical, Inc., SENOMYX INC, Ocera Therapeutics, Inc., CADENCE PHARMACEUTICALS INC, Achaogen Inc, Regado Biosciences Inc, ACHILLION PHARMACEUTICALS INC, Celator Pharmaceuticals Inc, SANTARUS INC, Somaxon Pharmaceuticals, Inc., ALIGN TECHNOLOGY INC, SENORX INC, NEOSE TECHNOLOGIES INC, and CARDIAC SCIENCE INC.

SEC CIK

Brian H Dovey's CIK is 0001207786

Past Insider Trading and Trends

2007 was Brian H Dovey's most active year for acquiring shares with 4 total transactions. Brian H Dovey's most active month to acquire stocks was the month of April. 2008 was Brian H Dovey's most active year for disposing of shares, totalling 21 transactions. Brian H Dovey's most active month to dispose stocks was the month of April. 2014 saw Brian H Dovey paying a total of $0.00 for 65,000 shares, this is the most they've acquired in one year. In 2007 Brian H Dovey cashed out on 39,029 shares for a total of $804,387.69, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Dicerna Pharmaceuticals Inc

Investor
Updated Dec 20, 2017
Form 4
92.42%
12.36K
$3.19
Dec 20, 2017
25.73K
Options
Dec 18
Form 4
92.47%
1.67M
$3.19
Dec 20, 2017
3.47M
Options
Dec 18
Form 4
368.00
$100.00
$36.80K
Apr 12, 2017
368.00
Purchase
Apr 11
Form 4
49.63K
$100.00
$4.96M
Apr 12, 2017
49.63K
Purchase
Apr 11
Form 4
Feb 04, 2014
1.79M
Options
Feb 04
Form 3
Jan 29, 2014
Showing 6 results

Bionano Genomics, Inc.

Investor
Updated Aug 27, 2018
Form 4
-96.38%
-183.36K
$4.59
Aug 27, 2018
6.89K
Options
Aug 23
Form 4
-90.87%
-24.68M
$5.36
$1.64M
Aug 27, 2018
2.48M
Buy-Options
Aug 23
Form 3
Aug 21, 2018
Form 3
Aug 21, 2018
140.00
Form 3
Aug 21, 2018
Showing 5 results

CoLucid Pharmaceuticals, Inc.

Investor
Updated Sep 13, 2016
Form 4
-100.00%
-1.94M
Sep 13, 2016
Disposition
Sep 09
Form 4
-7.46%
-245.00
$8.45
-$2.07K
Aug 03, 2016
3.04K
Sale
Aug 01 - Aug 03
Form 4
-7.30%
-153.03K
$8.45
-$1.29M
Aug 03, 2016
1.94M
Sale
Aug 01 - Aug 03
Form 4
-6.67%
-149.76K
$6.96
-$1.04M
May 02, 2016
2.10M
Sale
Apr 28
Form 4
-6.68%
-235.00
$6.96
-$1.64K
May 02, 2016
3.28K
Sale
Apr 28
Form 4
May 11, 2015
3.52K
Options
May 11
Form 4
May 11, 2015
2.25M
Options
May 11
Form 3
May 05, 2015
Form 3
May 05, 2015
43.67K
Showing 9 results

MARINUS PHARMACEUTICALS INC

Investor
Updated Aug 07, 2014
Form 4
Aug 07, 2014
17.00K
Options
Aug 05
Form 4
20.40%
419.74K
$8.00
$3.36M
Aug 07, 2014
2.48M
Purchase
Aug 05
Form 3
Jul 31, 2014
Form 3
Jul 31, 2014
Form 3
Jul 31, 2014
42.55K
Showing 5 results

GLAUKOS Corp

Investor
Updated Jul 01, 2015
Form 4
Jul 01, 2015
876.08K
Options
Jun 30
Form 4
Jul 01, 2015
6.50K
Options
Jun 30
Form 4
-0.42%
-8.70K
$12.83
-$156.60K
Jul 01, 2015
2.07M
Options
Jun 30
Form 4
Jul 01, 2015
14.04K
Options
Jun 30
Form 3
Jun 24, 2015
Form 3
Jun 24, 2015
Form 3
Jun 24, 2015
Form 3
Jun 24, 2015
Form 3
Jun 24, 2015
63.20K
Showing 9 results

Atara Biotherapeutics, Inc.

Investor
Updated Oct 21, 2014
Form 4
13.10%
1.84K
$11.00
Oct 21, 2014
15.89K
Purchase
Oct 21
Form 4
13.11%
248.16K
$11.00
Oct 21, 2014
2.14M
Purchase
Oct 21
Form 3
Oct 15, 2014
Form 3
Oct 15, 2014
Showing 4 results

Aldeyra Therapeutics, Inc.

Investor
Updated May 07, 2014
Form 4
May 07, 2014
1.97M
Options
May 07
Form 4
137.20%
5.33K
May 05, 2014
9.21K
Options
May 01
Form 4
43.25%
589.41K
$6.58
$136.32
May 05, 2014
1.95M
Options
May 01
Form 3
May 01, 2014
Form 3
May 01, 2014
Form 3
May 01, 2014
10.36K
Showing 6 results

Syndax Pharmaceuticals Inc

Investor
Updated Mar 08, 2016
Form 4
Mar 08, 2016
13.93K
Options
Mar 08
Form 4
Mar 08, 2016
1.74M
Options
Mar 08
Form 4
Mar 08, 2016
5.64K
Options
Mar 08
Form 4
Mar 08, 2016
761.06K
Options
Mar 08
Form 3
Mar 02, 2016
Form 3
Mar 02, 2016
Form 3
Mar 02, 2016
Form 3
Mar 02, 2016
Form 3
Mar 02, 2016
13.56K
Showing 9 results

Alliqua BioMedical, Inc.

Investor
Updated May 13, 2019
Form 3
May 13, 2019
22.53K
Form 3
May 13, 2019
3.04M
Showing 2 results

OBALON THERAPEUTICS INC

Investor
Updated Aug 08, 2019
Form 4
77.65%
437.50K
$4.00
$1.75M
Aug 08, 2019
1.00M
Purchase
Aug 06
Form 4
41.35%
1.65M
$1.82
$3.00M
Aug 27, 2018
5.63M
Purchase
Aug 23
Form 4
7.91%
3.63K
Oct 14, 2016
49.57K
Options
Oct 12
Form 4
5.65%
213.04K
Oct 14, 2016
3.99M
Options
Oct 12
Form 3
Oct 05, 2016
Form 3
Oct 05, 2016
Showing 6 results

aTYR PHARMA INC

Investor
Updated May 12, 2015
Form 4
-87.57%
-94.46K
May 12, 2015
13.41K
Options
May 12
Form 4
-87.56%
-12.73M
May 12, 2015
1.81M
Options
May 12
Form 3
May 06, 2015
Form 3
May 06, 2015
Form 3
May 06, 2015
12.57K
Showing 5 results

OTONOMY, INC.

Investor
Updated May 29, 2015
Form 4
-13.76%
-217.25K
May 29, 2015
1.37M
Disposition
May 28
Form 4
-2.31%
-277.00
$12.40
-$19.42
Aug 18, 2014
11.72K
Options
Aug 18
Form 4
-2.30%
-37.22K
$12.40
-$17.55
Aug 18, 2014
1.58M
Options
Aug 18
Form 3
Aug 12, 2014
Form 3
Aug 12, 2014
Showing 5 results

Neothetics, Inc.

Investor
Updated Dec 10, 2014
Form 4/A
-81.56%
-212.39K
$11.27
-$37.56K
Dec 10, 2014
48.03K
Options
Nov 25
Form 4/A
-81.29%
-13.43M
$11.86
-$2.20M
Dec 10, 2014
3.09M
Buy-Options
Nov 25
Form 3/A
Nov 26, 2014
Form 3/A
Nov 26, 2014
Form 4
-81.56%
-212.39K
$11.27
-$37.56K
Nov 26, 2014
48.02K
Options
Nov 25
Form 4
-81.29%
-13.43M
$11.86
-$2.20M
Nov 26, 2014
3.09M
Buy-Options
Nov 25
Form 3
Nov 19, 2014
Form 3
Nov 19, 2014
3.93K
Form 3
Nov 19, 2014
Showing 9 results

Durata Therapeutics, Inc.

Investor
Updated Nov 18, 2014
Form 4
-100.00%
-3.01M
Nov 18, 2014
Disposition
Nov 17
Form 4
-100.00%
-22.31K
Nov 18, 2014
Disposition
Nov 17
Form 4
-100.00%
-6.25K
Nov 18, 2014
Disposition
Nov 17
Form 4
34.95%
784.31K
$9.00
Jul 24, 2012
3.03M
Purchase
Jul 24
Form 3
Jul 18, 2012
6.25K
Showing 5 results

CADENCE PHARMACEUTICALS INC

Investor
Updated Jan 29, 2013
Form 4/A
-1.88%
-154.55K
$5.43
-$839.30K
Jan 29, 2013
8.06M
Sale
ScheduledJan 24 - Jan 25
Form 3
Oct 24, 2006
27.50K
Showing 2 results

Regado Biosciences Inc

Investor
Updated May 06, 2015
Form 3
May 06, 2015
47.61K
Form 3
May 06, 2015
3.28M
Form 3
Aug 21, 2013
53.10K
Showing 3 results

Esperion Therapeutics, Inc.

Investor
Updated Mar 24, 2015
Form 4
-13.63%
-350.00K
Mar 24, 2015
2.22M
Disposition
Mar 20
Form 4
24.19%
500.00K
$20.00
$10.00M
Oct 21, 2014
2.57M
Purchase
Oct 21
Form 4
-6.08%
-140.72K
$14.00
Jul 02, 2013
2.17M
Buy-Options
Jul 01
Form 3
Jun 25, 2013
21.47K
Showing 4 results

Clovis Oncology, Inc.

Investor
Updated Jun 05, 2013
Form 4
-5.94%
-2.78K
$64.58
-$179.47K
Jun 05, 2013
44.03K
Sale
Jun 04
Form 4
-5.81%
-159.19K
$64.58
-$10.28M
Jun 05, 2013
2.58M
Sale
Jun 04
Form 4
-8.36%
-250.00K
$24.59
-$6.15M
Mar 06, 2013
2.74M
Sale
Mar 04 - Mar 06
Form 4
-8.23%
-4.20K
$24.59
-$103.30K
Mar 06, 2013
46.81K
Sale
Mar 04 - Mar 06
Form 4
-43.70%
-2.36M
$13.00
Nov 21, 2011
3.04M
Buy-Options
Nov 21
Form 3
Nov 15, 2011
32.76K
Showing 6 results

ALIMERA SCIENCES INC

Investor
Updated Jan 17, 2014
Form 4
-7.63%
-296.76K
$6.39
-$1.90M
Jan 17, 2014
3.59M
Sale
ScheduledJan 15 - Jan 16
Form 4
-8.49%
-3.24K
$6.39
-$20.70K
Jan 17, 2014
34.91K
Sale
ScheduledJan 15 - Jan 16
Form 4
-0.30%
-114.00
$5.01
-$571.14
Jun 24, 2013
38.15K
Sale
ScheduledJun 20
Form 4
-0.27%
-10.52K
$5.01
-$52.69K
Jun 24, 2013
3.89M
Sale
ScheduledJun 20
Form 4
-1.55%
-603.00
$5.39
-$3.25K
Jun 20, 2013
38.26K
Sale
ScheduledJun 18 - Jun 19
Form 4
-1.40%
-55.28K
$5.39
-$297.83K
Jun 20, 2013
3.90M
Sale
ScheduledJun 18 - Jun 19
Form 4
-3.44%
-1.38K
$5.29
-$7.32K
Jun 18, 2013
38.86K
Sale
ScheduledJun 14 - Jun 17
Form 4
-3.11%
-126.71K
$5.29
-$669.84K
Jun 18, 2013
3.95M
Sale
ScheduledJun 14 - Jun 17
Form 4
-0.15%
-59.00
$5.00
-$295.00
Jun 13, 2013
40.25K
Sale
ScheduledJun 11
Form 4
-0.13%
-5.34K
$5.00
-$26.68K
Jun 13, 2013
4.08M
Sale
ScheduledJun 11
Form 4
-1.18%
-483.00
$4.60
-$2.22K
May 17, 2013
40.31K
Sale
May 15 - May 16
Form 4
-1.07%
-44.24K
$4.60
-$203.68K
May 17, 2013
4.09M
Sale
May 15 - May 16
Form 4
-14.11%
-688.05K
$8.04
-$55.59K
Jun 03, 2011
4.19M
Sale
Jun 02
Form 4
8.40%
378.03K
$11.00
Apr 27, 2010
4.88M
Purchase
Apr 27
Form 3
Apr 21, 2010
Showing 15 results

Evoke Pharma Inc

Investor
Updated May 27, 2016
Form 4
-36.28%
-5.88K
$4.70
-$27.64K
May 27, 2016
10.33K
Sale
May 26
Form 4
-36.21%
-344.12K
$4.70
-$1.62M
May 27, 2016
606.28K
Sale
May 26
Form 4
-0.50%
-82.00
$5.07
-$415.42
Apr 27, 2016
16.21K
Sale
Apr 25 - Apr 27
Form 4
-0.53%
-5.09K
$5.07
-$25.85K
Apr 27, 2016
950.40K
Sale
Apr 25 - Apr 27
Form 4
-4.17%
-708.00
$5.35
-$3.79K
Apr 21, 2016
16.29K
Sale
Apr 19 - Apr 20
Form 4
-4.16%
-41.48K
$5.35
-$222.01K
Apr 21, 2016
955.50K
Sale
Apr 19 - Apr 20
Form 4
-0.44%
-75.00
$5.22
-$391.50
Apr 13, 2016
17.00K
Sale
Apr 11
Form 4
-0.43%
-4.35K
$5.22
-$22.70K
Apr 13, 2016
996.98K
Sale
Apr 11
Form 4
-4.87%
-874.00
$5.28
-$4.61K
Apr 08, 2016
17.07K
Sale
Apr 06 - Apr 08
Form 4
-4.85%
-51.00K
$5.28
-$269.24K
Apr 08, 2016
1.00M
Sale
Apr 06 - Apr 08
Form 4
-1.11%
-202.00
$7.02
-$1.42K
Aug 20, 2015
17.95K
Sale
Aug 18
Form 4
-1.11%
-11.84K
$7.02
-$83.09K
Aug 20, 2015
1.05M
Sale
Aug 18
Form 4
-4.50%
-50.16K
$7.29
-$365.67K
Apr 16, 2015
1.06M
Sale
Apr 14 - Apr 16
Form 4
-4.51%
-857.00
$7.29
-$6.25K
Apr 16, 2015
18.15K
Sale
Apr 14 - Apr 16
Form 4
Sep 30, 2013
1.14M
Options
Sep 30
Form 3
Sep 24, 2013
5.25K
Showing 16 results

Ocera Therapeutics, Inc.

Investor
Updated Dec 13, 2017
Form 4
-100.00%
-47.96K
Dec 13, 2017
Disposition
Dec 11
Form 4
-100.00%
-15.73K
Dec 13, 2017
Disposition
Dec 11
Form 4
-100.00%
-1.90M
Dec 13, 2017
Disposition
Dec 11
Form 4
-100.00%
-7.33K
Dec 13, 2017
Disposition
Dec 11
Form 4
-100.00%
-988.28K
Dec 13, 2017
Disposition
Dec 11
Form 4/A
87.04%
1.33M
$6.03
$8.00M
Jul 31, 2013
2.92M
Purchase
Jul 15
Form 3/A
Jul 31, 2013
1.59M
Form 4
84.80%
1.33M
$6.03
$8.00M
Jul 16, 2013
2.96M
Purchase
Jul 15
Form 3
Jul 16, 2013
1.63M
Showing 9 results

VERACYTE, INC.

Investor
Updated Sep 12, 2014
Form 4
-9.79%
-300.00K
Sep 12, 2014
2.76M
Disposition
Sep 10
Form 4
Nov 04, 2013
3.09M
Options
Nov 04
Form 3
Oct 29, 2013
Showing 3 results

Volcano Corp

Investor
Updated Jul 28, 2008
Form 4/A
-20.03%
-1.15M
$14.49
-$280.48K
Jul 28, 2008
4.59M
Sale
Jul 16
Form 4/A
-20.03%
-1.15M
$14.49
-$280.48K
Jul 28, 2008
4.59M
Sale
Jul 16
Form 4
-20.03%
-1.15M
$14.49
-$280.48K
Jul 18, 2008
4.59M
Sale
Jul 16
Form 4
-20.03%
-1.15M
$14.49
-$280.48K
Jul 18, 2008
4.59M
Sale
Jul 16
Form 4
54.20%
29.94K
Jun 09, 2008
85.18K
Acquisition
Apr 24
Form 4
-100.00%
-39.03K
$20.61
-$804.39K
Jun 05, 2008
Sale
Jun 14
Form 4
-100.00%
-10.26K
$13.46
-$138.09K
Jun 04, 2008
Sale
Jun 02 - Jun 03
Form 4/A
-63.95%
-18.20K
$13.98
-$254.52K
Jun 04, 2008
10.26K
Sale
May 29 - May 30
Form 4
-62.19%
-17.70K
$13.99
-$247.58K
Jun 02, 2008
10.76K
Sale
May 29 - May 30
Form 4
-14.83%
-1.00M
$12.98
-$218.48K
Apr 10, 2008
5.74M
Sale
Apr 08
Form 4
2,866.60%
53.38K
Sep 12, 2007
55.24K
Acquisition
Sep 12
Form 4/A
40.89K
Jun 14, 2007
40.89K
Acq/Dis
May 25
Form 4
39.03K
May 29, 2007
39.03K
Acq/Dis
May 25
Form 4
-18.20%
-25.25K
$19.25
-$486.00K
May 22, 2007
113.48K
Sale
May 18
Form 4
-14.87%
-1.20M
May 11, 2007
6.90M
Disposition
May 10
Form 4/A
-15.47%
-1.51M
$16.75
-$25.26M
Dec 11, 2006
8.24M
Sale
Dec 06
Form 4
-15.47%
-1.51M
$16.75
-$25.26M
Dec 08, 2006
8.24M
Sale
Dec 06
Form 4
Jun 20, 2006
9.75M
Options
Jun 20
Form 3
Jun 14, 2006
Showing 19 results

Orexigen Therapeutics, Inc.

Investor
Updated Jul 18, 2017
Form 4
5.00K
Jul 18, 2017
5.00K
Grant
Jul 14
Form 4
15.00K
Jul 14, 2016
15.00K
Grant
Jul 12
Form 4
50.00K
Jun 10, 2015
50.00K
Grant
Jun 09
Form 4
50.00K
Jun 30, 2014
50.00K
Grant
Jun 27
Form 4
121.06%
4.22M
$5.30
-$4.33
Apr 23, 2014
7.71M
Options
Apr 22
Form 4
35.00K
Jun 06, 2013
35.00K
Grant
Jun 05
Form 4
35.00K
Jun 12, 2012
35.00K
Grant
Jun 07
Form 4
36.81%
938.29K
$7.97
$7.48M
Dec 22, 2011
3.49M
Purchase
Dec 22
Form 4
20.00K
Jun 03, 2011
20.00K
Grant
Jun 02
Form 4
20.00K
May 28, 2010
20.00K
Grant
May 27
Form 4
2.83%
138.10K
$7.53
$1.04M
Dec 21, 2009
5.02M
Purchase
Dec 17 - Dec 18
Form 4
2.12%
50.00K
$6.75
$337.50K
Nov 25, 2009
2.41M
Purchase
Nov 24
Form 4
20.40%
400.00K
$6.93
$2.77M
Nov 24, 2009
2.36M
Purchase
Nov 20 - Nov 23
Form 4
3.27%
62.00K
$6.90
$427.80K
Nov 16, 2009
1.96M
Purchase
Nov 12
Form 4
7.84%
138.00K
$6.93
$956.34K
Nov 12, 2009
1.90M
Purchase
Nov 10 - Nov 11
Form 4
0.79%
13.78K
$7.73
$106.55K
Aug 19, 2009
1.76M
Purchase
Aug 18
Form 4
5.39%
89.43K
$7.75
$692.66K
Aug 18, 2009
1.75M
Purchase
Aug 14 - Aug 17
Form 4
33.18%
413.00K
$8.00
$3.30M
Aug 14, 2009
1.66M
Purchase
Aug 12 - Aug 13
Form 4
9.15%
104.30K
$7.60
$792.68K
Aug 13, 2009
1.24M
Purchase
Aug 11
Form 4
132.57%
650.00K
$7.50
$4.88M
Jul 24, 2009
1.14M
Purchase
Jul 23
Form 4
12.50K
May 29, 2009
12.50K
Grant
May 27
Form 4
490.30K
$4.70
$2.30M
Dec 10, 2008
490.30K
Purchase
Dec 08 - Dec 09
Form 4
25.00K
Jun 12, 2008
25.00K
Grant
Jun 10
Form 4
-19.76%
-898.91K
$14.27
-$299.67K
Nov 29, 2007
3.65M
Sale
Nov 27
Form 4
13.05%
525.00K
$12.00
May 01, 2007
4.55M
Purchase
May 01
Form 3
Apr 25, 2007
260.00K
Showing 26 results

ZOGENIX, INC.

Investor
Updated Sep 20, 2011
Form 4
53.09%
3.50M
$2.00
$7.00M
Sep 20, 2011
10.09M
Purchase
Sep 16
Form 4
55.26%
2.35M
$4.00
Dec 01, 2010
6.60M
Purchase
Nov 29
Form 3
Nov 22, 2010
11.00K
Showing 3 results

Northstar Neuroscience, Inc.

Investor
Updated May 11, 2006
Form 4
-33.33%
-1.05M
May 11, 2006
2.11M
Options
May 10
Form 3
May 04, 2006
3.33K
Showing 2 results

INTRALASE CORP

Investor
Updated Oct 13, 2004
Form 4
-20.49%
-524.60K
Oct 13, 2004
2.04M
Options
Oct 13
Form 3
Oct 06, 2004
Showing 2 results

IOMAI CORP

Investor
Updated Feb 07, 2006
Form 4
Feb 07, 2006
1.74M
Options
Feb 06
Form 3/A
Feb 01, 2006
Form 3
Jan 25, 2006
Showing 3 results

TANDEM DIABETES CARE INC

Investor
Updated Nov 19, 2013
Form 4
-6.30%
-242.11K
Nov 19, 2013
3.60M
Options
Nov 19
Form 3
Nov 13, 2013
Showing 2 results

Vanda Pharmaceuticals Inc.

Investor
Updated Dec 13, 2006
Form 4
-22.64%
-584.29K
$25.62
-$330.50K
Dec 13, 2006
2.00M
Sale
Dec 12
Form 4
-19.67%
-623.33K
Nov 03, 2006
2.55M
Disposition
Nov 03
Form 4
-69.79%
-7.40M
Apr 18, 2006
3.20M
Options
Apr 18
Form 3
Apr 12, 2006
Showing 4 results

NUVASIVE INC

Investor
Updated May 20, 2004
Form 4
-58.58%
-2.52M
$5.60
$109.33K
May 20, 2004
1.78M
Options
May 18
Form 3
May 12, 2004
8.00K
Showing 2 results

NOVACEA INC

Investor
Updated Jan 30, 2009
Form 4
-7.75%
-250.00K
$0.96
-$238.75K
Jan 30, 2009
2.98M
Sale
Jan 28 - Jan 30
Form 4
-24.98%
-24.50K
$11.26
-$275.87K
Jun 06, 2007
73.58K
Sale
Jun 06
Form 4
-20.09%
-834.30K
Jun 05, 2007
3.32M
Disposition
Jun 04
Form 4
7.92M
$6.50
May 16, 2006
4.25M
Purchase
May 15
Form 3
May 09, 2006
157.50K
Showing 5 results

REVA Medical, Inc.

Investor
Updated Nov 13, 2019
Form 4
-100.00%
-3.72M
-$3.10
Nov 13, 2019
Sale
Nov 11
Form 4
Jul 03, 2018
3.72M
Acq/Dis
Jun 29
Form 4
25.00K
May 18, 2018
25.00K
Grant
May 16
Form 4
Jul 27, 2017
3.72M
Acq/Dis
Jul 25
Form 4
94.29%
16.50K
Jul 11, 2017
3.73M
Grant
Jul 09
Form 4
Aug 01, 2016
3.72M
Acq/Dis
Aug 01
Form 4
145.33%
21.80K
May 27, 2016
3.73M
Grant
May 25
Form 4
15.00K
May 29, 2015
3.71M
Grant
May 27
Form 4
15.00K
May 14, 2014
15.00K
Grant
May 12
Form 4
15.00K
May 31, 2013
15.00K
Grant
May 29
Form 4/A
12.50K
Jul 27, 2012
12.50K
Grant
May 20
Form 4
12.50K
May 22, 2012
12.50K
Grant
May 21
Form 4
-31.48%
-1.70M
$5.16
-$8.75M
Mar 27, 2012
3.69M
Sale
Mar 23
Form 4
-3.22%
-179.49K
$3.54
Dec 20, 2010
5.39M
Options
Dec 16
Form 3
Nov 15, 2010
Showing 15 results

SENOMYX INC

Investor
Updated Jun 25, 2004
Form 4
-8.70%
-147.81K
Jun 25, 2004
1.55M
Options
Jun 25
Form 3/A
Jun 24, 2004
61.20K
Form 3
Jun 17, 2004
61.20K
Showing 3 results

Achaogen Inc

Investor
Updated Mar 11, 2014
Form 3
Mar 11, 2014
Showing 1 results

ACHILLION PHARMACEUTICALS INC

Investor
Updated Jan 18, 2013
Form 4
-13.60%
-933.54K
Jan 18, 2013
6.02M
Disposition
Jan 18
Form 4
-13.88%
-1.11M
Jun 04, 2012
6.95M
Disposition
May 31
Form 4
25.00K
Oct 08, 2010
25.00K
Acq/Dis
Oct 06
Form 3
Aug 23, 2010
8.03M
Showing 4 results

Celator Pharmaceuticals Inc

Investor
Updated Jan 15, 2013
Form 3
Jan 15, 2013
2.24M
Showing 1 results

SANTARUS INC

Investor
Updated Apr 08, 2004
Form 4
Apr 08, 2004
2.79M
Options
Apr 06
Form 3
Mar 31, 2004
Showing 2 results

Somaxon Pharmaceuticals, Inc.

Investor
Updated Dec 22, 2006
Form 4
-24.50%
-567.85K
$13.52
-$87.33K
Dec 22, 2006
1.75M
Sale
Dec 21
Form 4
-20.00%
-6.46K
$13.03
-$84.16K
Sep 20, 2006
25.84K
Sale
Sep 18
Form 4
-19.78%
-565.16K
Sep 14, 2006
2.29M
Disposition
Sep 13
Form 4
-83.33%
-14.45M
Dec 20, 2005
2.89M
Options
Dec 20
Form 3
Dec 14, 2005
19.17K
Showing 5 results

ALIGN TECHNOLOGY INC

Investor
Updated May 20, 2004
Form 4
8.00K
May 20, 2004
8.00K
Grant
May 19
Form 4
-100.00%
-69.15K
$11.03
-$762.46K
Aug 08, 2003
Sale
Aug 08
Form 4
-64.19%
-123.96K
Aug 08, 2003
69.15K
Disposition
Aug 08
Form 4
-92.37%
-1.40M
Aug 01, 2003
115.23K
Disposition
Jul 31
Form 4
Jun 03, 2003
Form 4
May 16, 2003
Showing 6 results

SENORX INC

Investor
Updated Apr 03, 2007
Form 4
-69.74%
-3.16M
Apr 03, 2007
1.37M
Options
Apr 03
Form 3
Mar 28, 2007
Showing 2 results

NEOSE TECHNOLOGIES INC

Investor
Updated Feb 11, 2009
Form 4
Feb 11, 2009
2.87K
Options
Jan 27
Form 4
10.00K
May 08, 2007
10.00K
Grant
May 04
Form 4
377.89%
3.59M
Mar 13, 2007
4.54M
Purchase
Mar 09
Form 4
10.00K
May 05, 2006
10.00K
Grant
May 04
Form 4
12.87K
May 05, 2005
12.87K
Grant
May 03
Form 4
10.00K
May 07, 2004
10.00K
Grant
May 06
Form 4
May 14, 2003
Form 3
May 14, 2003
Showing 8 results

CARDIAC SCIENCE INC

Investor
Updated Sep 01, 2005
Form 4
-100.00%
-7.06M
Sep 01, 2005
Disposition
Sep 01
Form 4
45.00K
Oct 10, 2003
45.00K
Grant
Oct 09
Showing 2 results